ArticleJACC. Advances2026
In-Hospital Outcomes After Tricuspid Valve Surgery in the United States: Impact of Surgical Center Volumes.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe impact of institutional experience on postoperative outcomes among patients undergoing isolated or concomitant tricuspid valve operations is not well studied.
objectivesThe authors characterized the presence of a potential volume-outcome relationship between center-level cardiac valve procedural volume and risks of in-hospital mortality as well as resource utilization in a national cohort.
methodsThe 2016 to 2022 Nationwide Readmissions Database was reviewed to identify all adults undergoing isolated or concomitant tricuspid valve replacement or repair. A multivariable regression model was developed to evaluate mortality and hospitalization costs. Hospitals were categorized as high (HVH) or low volume based on explanatory analysis. The association of HVH status with postoperative complications, length of stay, and 30-day nonelective readmission were subsequently examined.
resultsOf an estimated 35,567 patients, 21,723 (61.0%) were treated at HVH. Compared to low-volume hospital, HVH patients were older, less commonly females, and more commonly of the highest income quartile. Patients at HVH more frequently received an isolated operation (21.0 vs 20.2%; P = 0.01). Following risk-adjustment, treatment at an HVH was associated with lower odds of mortality (adjusted OR: 0.56; 95% CI: 0.47-0.68) and cardiac complications (adjusted OR: 0.83; 95% CI: 0.73-0.94). However, HVH status was associated with increased costs by $6,070, but lower odds of nonhome discharge and 30-day nonelective readmission.
conclusionsHVH status was associated with lower odds of in-hospital mortality and reduced risk of 30-day nonelective readmission, but greater hospitalization costs. Increased outreach and resource availability at low-volume centers may help alleviate this disparity and enhance the overall value of care in tricuspid valve surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.